Enzo Biochem, Inc. stock is down -0.79% since 30 days ago. The next earnings date is Dec 22, 2023. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 29 December’s closed higher than November.
Enzo Biochem, Inc. researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. It markets its products and services through its direct sales force and a network of distributors in the United States and internationally.